- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06815601
Neuromodulation After Spinal Cord Injury to Improve Limb Function
September 3, 2026 updated by: Hang Jin Jo, State University of New York at Buffalo
The University at Buffalo (UB) Department of Rehabilitation Sciences is looking for adult volunteers with and without spinal cord injuries for a study on hand movement.
The goal of the study is to learn about how the brain, nerves, and muscles of the body are connected and perform everyday tasks.
This may help us to develop ways to improve the hand functions of people with spinal cord injuries.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The main goal of rehabilitation strategies in humans with spinal cord injury (SCI) is to strengthen transmission in spared neural networks to restore functional movements.
Recent evidence showed that neuromodulation approaches may increase the transmission in corticospinal pathway in humans with SCI and improve functional outcomes.
Therefore, the investigators aim to investigate how the noninvasive brain stimulation protocols affects neuroplasticity of corticospinal pathway.
Specifically, the investigators will use the repetitive transcranial magnetic stimulation (rTMS) to explore its effect.
The investigators will investigate the effect of short-term and long-term rTMS application in individuals with SCI.
Study Type
Interventional
Enrollment (Actual)
17
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14214
- The Kimball Tower at The State University of New York at Buffalo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy adults between the ages of 18-75 years old who are right-handed
- Adults between the ages of 18-75 years old who have had a spinal cord injury (SCI)
Exclusion Criteria:
For both healthy individuals and those with SCI:
- Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease
- Any debilitating disease prior to the SCI that caused exercise intolerance
- Ongoing major depression or altered cognitive status
- Metal plate in skull
- History of seizures
- Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs
- Pregnant females
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: rTMS first and then sham-rTMS
rTMS or sham-rTMS will be administered and functional and physiological outcomes will be measured before and after each intervention.
In this Arm, participants will have rTMS session first and then sham-rTMS.
|
Intermittent theta burst stimulation (iTBS) will be utilized since they have been reported to have a cortical neuromodulatory effect.
The iTBS protocol will be applied over primary motor cortex to investigate its effect on corticospinal excitability and functional outcome.
Theta burst stimulation (TBS) consists of bursts of pulses containing 3 pulses at 50 Hz (3 pulses per second) repeated at 200 ms intervals (5 Hz).
During iTBS, a 2 second train of TBS is repeated every 10 seconds (600 pulses in 190 seconds).
Other Names:
Sham iTBS protocols will be applied with the same parameters as in iTBS protocol.
However, sham coil will be used.
Other Names:
|
|
Experimental: Sham rTMS and then rTMS
rTMS or sham-rTMS will be administered and functional and physiological outcomes will be measured before and after each intervention.
In this Arm, participants will have sham-rTMS session first and then rTMS.
|
Intermittent theta burst stimulation (iTBS) will be utilized since they have been reported to have a cortical neuromodulatory effect.
The iTBS protocol will be applied over primary motor cortex to investigate its effect on corticospinal excitability and functional outcome.
Theta burst stimulation (TBS) consists of bursts of pulses containing 3 pulses at 50 Hz (3 pulses per second) repeated at 200 ms intervals (5 Hz).
During iTBS, a 2 second train of TBS is repeated every 10 seconds (600 pulses in 190 seconds).
Other Names:
Sham iTBS protocols will be applied with the same parameters as in iTBS protocol.
However, sham coil will be used.
Other Names:
|
|
Experimental: rTMS with motor training
Subjects will receive the rTMS with motor training for long-term up to 50 sessions.
Motor training involves hand motor training.
|
Intermittent theta burst stimulation (iTBS) will be utilized since they have been reported to have a cortical neuromodulatory effect.
The iTBS protocol will be applied over primary motor cortex to investigate its effect on corticospinal excitability and functional outcome.
Theta burst stimulation (TBS) consists of bursts of pulses containing 3 pulses at 50 Hz (3 pulses per second) repeated at 200 ms intervals (5 Hz).
During iTBS, a 2 second train of TBS is repeated every 10 seconds (600 pulses in 190 seconds).
Other Names:
The motor training will be focused on participant's hand motor function such as grasping function.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor Evoked Potentials (MEP)
Time Frame: For "rTMS" and "Sham rTMS", the time frame will be one day, before and after each session. For "rTMS with motor training", MEPs will be measured twice, before the start of the first session and after the 10th session, at 4 weeks.
|
Transcranial magnetic stimuli (TMS) will be delivered through a figure-of-eight coil over primary motor cortex to the optimal scalp position for activation of hand muscles.
The optimal scalp position will be determined by moving the coil in small steps along the hand representations of the primary motor cortex to find the region where the largest MEP can be evoked with the minimum intensity in the targeted muscle.
Twenty MEPs will be collected and the peak-to-peak amplitude of MEP measured in millivolts will be averaged across trials.
MEPs will be collected before (pre) and after (post) each intervention and the post-MEP amplitude will be normalized by pre-MEP amplitude.
Therefore, the MEP outcomes reported will be "(post-MEP/pre-MEP)x100".
|
For "rTMS" and "Sham rTMS", the time frame will be one day, before and after each session. For "rTMS with motor training", MEPs will be measured twice, before the start of the first session and after the 10th session, at 4 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximum voluntary contraction (MVC)
Time Frame: For "rTMS" and "Sham rTMS", the time frame will be one day, before and after each session. For "rTMS with motor training", the time frame will be weekly up to 20 weeks.
|
Individuals will perform a MVC of the targeted hand muscle (first dorsal interosseous) through surface EMG electrodes.
The investigators will collect two MVC trials and use the average of the two.
|
For "rTMS" and "Sham rTMS", the time frame will be one day, before and after each session. For "rTMS with motor training", the time frame will be weekly up to 20 weeks.
|
|
Power Grip Forces
Time Frame: For "rTMS" and "Sham rTMS", the time frame will be one day, before and after each session. For "rTMS with motor training", the time frame will be weekly up to 20 weeks.
|
Power grip force will be measured with hand-held dynamometer.
|
For "rTMS" and "Sham rTMS", the time frame will be one day, before and after each session. For "rTMS with motor training", the time frame will be weekly up to 20 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Hang Jin Jo, PhD, State University of New York at Buffalo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 10, 2025
Primary Completion (Actual)
November 14, 2025
Study Completion (Actual)
November 14, 2025
Study Registration Dates
First Submitted
January 24, 2025
First Submitted That Met QC Criteria
February 3, 2025
First Posted (Actual)
February 7, 2025
Study Record Updates
Last Update Posted (Actual)
September 8, 2026
Last Update Submitted That Met QC Criteria
September 3, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Central Nervous System Diseases
- Nervous System Diseases
- Wounds and Injuries
- Trauma, Nervous System
- Spinal Cord Diseases
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Spinal Cord Injuries
- Paralysis
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Exercise
Other Study ID Numbers
- 00007259
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.